Pin1 exacerbates NAFLD by inhibiting AMPK-mediated inactivation of ACC1 and its downstream signalling pathways, promoting hepatic lipid aggregation, insulin resistance, and fibrosis. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.